In January 2025, Ozempic was further approved to reduce the risk of kidney disease progression, kidney failure, and cardiovascular death in T2D with chronic kidney disease, making it the most broadly indicated GLP-1 RA currently available
Am J Physiol 1993;265(4 Pt 1):L374L381
It is also important to note that clomiphene may increase the likelihood of twin pregnancy
FDA green-lights tirzepatide, marketed as Zepbound, for chronic weight management
Under the terms of the deal, the company will gain the exclusive global license to develop, manufacture, and commercialize Chinese drugmaker Hansoh Pharmaceutical Group Co.s HS-10535, an experimental oral drug that targets the receptors for GLP-1, Merck said in a statement Wednesday
Now, what if a freezer isn't available